Investment IdeasMy Portfolio
All Investment Ideas
$6 mln$17 mln$75 mln$130 mln

Zocdoc

Online medical care appointment booking service
Pre-IPO
High risk

Funding rounds A-D

Invest in Zocdoc

Please, log in or sign up to invest in Zocdoc

Investment Idea Details
About the company

ZocDoc is a company that operates an online platform for finding and booking medical appointments in the neighborhood. It also offers appointment and preventive check-up reminders along with online paperwork services.

With the rise of telehealth services in the wake of the global pandemic, the company is launching a new tool that will see it play a more active part in connecting patients to doctors. It’s partnering with communications platform Twilio to launch Zocdoc Video Service (ZVS).

Market Opportunities

Zocdoc’s founder and CEO Oliver Kharraz told Engadget that video visits now account for 30 to 40 percent of overall bookings, up from “essentially zero at the beginning of March.

The global telemedicine market size is expected to reach USD 155.1 billion by 2027, expanding at a CAGR of 15.1% over the forecast period. Increasing incidences of chronic conditions and rising demand for self-care medicines are the key factors driving the market.

Risks

Zocdoc has not disclosed financials. As a result, it is unknown whether the company is profitable or has a path to profitability.

Intensified Competition - more competitors/healthcare IT providers are eyeing the doctor’s appointment space.

Potentially Constrained Growth. As Zocdoc has already tapped into most major US metropolitan areas, further expansion in the US may be constrained.

Financials and Valuation

Zocdoc has raised a total of $225.9M in funding over 9 rounds. Zocdoc has received financing from Founders Fund, Khosla Ventures and Goldman Sachs.

Zocdoc has not disclosed financials. Zocdoc, as of February 2017, serves doctors and other medical professionals in 53 cities in the US, including New York, Chicago, Houston, and Philadelphia, as listed on Zocdoc's website. As of June 2017, Zocdoc was already arranging over six million site visits per month.

Zocdoc might be acquired by a big company operating in healthcare digitization industry. The potential return on investment is 150%.

How Venture Investments Work
1. Searching for Companies

United Traders analysts are in continuous search for OTC offers studying financial reporting, companies’ businesses, their future plans, analyzing them as potential acquisition targets or estimating prospective multifold capitalization increase as well as considering risks that may hinder business growth. The best ideas are offered to our investors.

Publication
25 Sep
Minimum Amount
1 share
2. Buying shares

As part of our service for purchasing shares on the over-the-counter market (pre-IPO, OTC), for its traders and investors United Traders buys units in funds that own equity stakes in private companies. These funds make early-stage investments in private companies or acquire equity stakes from employees of such companies.

Shares Outstanding
Limited
3. Public Offering

United Traders will have shares at its disposal after the IPO. The shares can be sold after the established 6-month Lock-up period. Alternatively, the shares can be hedged for the above period. Prior to the company going public United Traders look for exit options in the OTC market. If we find a great offer, we sell the shares.

Public Offering Date
Pending
Estimated Gains
+150%
4. Taking profit

After the Lock-up period is over, the investment in pre-IPO or OTC will be automatically closed, and generated profits are credited to your account less the applicable UT fees. We offer an opportunity for investors with over $100,000 invested in a specific idea to search for a counterpart in the OTC market individually and to take profits before the company goes public and thereby exiting the trade prior to the Lock-up period expiration.

Exit
̴ 2021
Early Exit

Although it is prohibited to sell shares within the Lock-Up period, our traders find ways to take profits for our investors using various financial instruments: forwards, options, short selling trades, etc.

For an investor the above means that the pre-IPO or OTC investment may be exited after paying a part of its value, usually around 15% which is caused by highly-priced instruments used to close the position. To do so, you should press the respective button in your members area as soon as it becomes active.

The exiting process is similar to making a new investment. You submit a request, we execute it within 1 business day, and your investment is closed at the current exchange price.

Fees

ENTRY FEE

3.5% of the share purchase amount. The fee is charged at confirmation of your investment bid.

EXIT FEE

0.5% of the share sell amount after the trade. The fee is charged at the investment exit.

SUCCESS FEE

20% of the profit gain. The fee is charged only if the trade is profitable at the time of exiting.

EARLY EXIT FEE

Usually a 15% fee is charged subject to the actual situation at the exchange. The fee is calculated individually for each investment.

What Are the Benefits of Investing with United Traders?

WE ARE A RELIABLE PARTNER

Our risk managers will support you throughout the entire transaction life.

HIGH PROFITABILITY

Venture investing is very risky as they involve new or growing companies, and multifold increase in capitalization is expected. We prioritize companies at the pre-IPO stage as they already demonstrate strong financial indicators and plan to go public soon. This approach allows limiting hyper-risks related to insolvency of new companies and substantially increasing profits as compared to investors who buy shares through a subscription just before the IPO.

LOW ENTRY THRESHOLD

To buy the OTC stocks, one would need millions of dollars. We gathered a pool of traders and investors allowing everyone interested to join similar transactions with as much as $10.

Risks

United Traders is experienced in minimizing risks but a future investor should be aware of all risk types:

  • Illiquidity. There is a possibility that early exit from this investment will take more than 1 month.
  • Asymmetric information. Management and current investors have access to more internal information about the company than other market participants.
  • Time uncertainty. There is no information regarding next financing round or exit strategy timeframe (IPO or M&A).
  • Share dilution. The issue of additional shares by a company may reduce the value of shares of existing investors.

Invest in Zocdoc

Please, log in or sign up to invest in Zocdoc